Background: the assessment of microbiological quality of medicinal products is one of control stages in medicinal products saft, because the holder of a manufacturing authorization must drug so as to ensure that they are fit for their intended use, comply with the requirements of the Marketing Authorization and do not place patients at risk due to inadequate safety, quality or efficacy. Objective: To assess microbial limit test for hospital preparation ‘compound alum powder’. Methods: The results of strain culture and analysis were used to evaluate the drug quality of ‘compound alum powder’. The objective is ‘compound alum powder’ (approval number: Z20140229) was made by the First Affiliated Hospital of Jinan University. Their batch numbers include: 201019, 200818, 200701. Validation tests were carried out in accordance with the standards of the Chinese Pharmacopoeia (2020 edition). Three parallel independent validations were conducted to calculate the recovery rate of each test bacterium and investigate whether each test bacterium was detected in the control bacterial inspection. Result: The recovery ratio of the total number of aerobic bacteria, molds and yeast in the control group was in the range of 0.5 ~ 2, and the results of the control group were positive, and the results of each control group met the requirements. The results show that the membrane filtration method is suitable for the microbial limit test of ‘compound alum powder’. Conclusion: this microbial limit test method control and ensure the quality of drug production by solving the problem of interference of antimicrobial components in drugs. It can eliminate the bacteriostasis of boric acid, phenol and alum.
Published in | European Journal of Clinical and Biomedical Sciences (Volume 7, Issue 2) |
DOI | 10.11648/j.ejcbs.20210702.14 |
Page(s) | 33-36 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
Microbial Limit Test, ‘Compound Alum Powder’, Boric Acid, Phenol, Membrane Filtration
[1] | Tyski S. How to manufacture a pure and safe drug. Pharm. Ind. 2017; 5: 57–61. |
[2] | Guide to good manufacturing practice for medicinal products, 2017. Pharmaceutical Inspection Convention Pharmaceutical Inspection co-operation scheme, PE 009–10 (Part I) 1 January 2017. |
[3] | Długaszewska J, Muszyn ́ski Z, Ratajczak M. Microbiological purity of oral drugs manufactured in industrial and pharmacy environment. In: 26th Congress of the Polish Society of Microbiologists: Microbes –Challenges and Hopes. Conference Materials. Szczecin. 2018: 4–7. |
[4] | National Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China: four parts of the 2020 edition. Beijing: China Medical Science and Technology Press. 2020: 160-171. |
[5] | Yang XL, Li H, Ma YY, et al. Chinese Pharmacopoeia 2015 edition of the microbial limit test of non-sterile products: the introduction and countermeasures of bacterial control test [J]. Chinese Pharmacist. 2016; 19 (4): 748-752. |
[6] | You SX, Wu DK, Liu SJ, et al. Research on processing of Alumen. Joumal of Chinese Medicinal Materials. 2018; 33 (7): 1192-1194. |
[7] | She F, Xu ZG. Influencing factors and countermeasures of microbial limit testing error for drugs. China Health Standards Management. 2018; 9 (18): 100-102. |
[8] | Ma SH, Liu P, Yang LH, et al. Experimental study on adding bacteria in the applicability test of microbial limit test method for drug. Journal of Pharmaceutical Analysis. 2018; 38 (5): 877-882. |
[9] | Yang YR, Shen QL, Wang QF. Western China Journal of Traditional Chinese Medicine. 2017; 30 (11): 59-61. |
[10] | Wang ZJ, Mei LQ, Wang XJ, et al. Study on the applicability of microbial limit test for six traditional Chinese medicine preparations. Pharmaceutical Care and Research. 2018; 18 (4): 300-303. |
[11] | Min H, Tang N, Yi LJ. Microbial limit and control method of traditional Chinese medicine preparation. Northwestern Pharmaceutical Journal. 2016; 28 (3): 301-303. |
[12] | Wang J, Zhang XH, Ren ZL, Sheng CL, Yan SS. Study on the applicability of the microbial limit test method of Yangyin Qingfei pill. China Contemporary Medicine. 2020; 27 (36): 29-32. |
[13] | Gong Y, Li M, Cao J, Zhang R. Establishment of four kinds of microbial limit test methods of hospital Chinese medicine preparation containing Chinese herbal powder. Evaluation and Analysis of Hospital Drug Use in China. 2020; 20 (10): 1197-1199+1203. |
[14] | Wei YY, He K, Wu YM, Wang XX, Pang YJ. Guangzhou Chemical Industry. 2020; 48 (19): 89-91. |
[15] | Zhang XH, Liu YP, Qu GJ. Establishment of microbial limit test method for compound Danshen tablets. China Pharmaceutical Standard. 2020; 21 (05): 464-471. |
APA Style
Fangming Tan, Minna Huang, Suishan Qiu, Zhuanzhi Liang. (2021). Establishment of Microbial Limit Test for Hospital Preparation ‘Compound Alum Powder’. European Journal of Clinical and Biomedical Sciences, 7(2), 33-36. https://doi.org/10.11648/j.ejcbs.20210702.14
ACS Style
Fangming Tan; Minna Huang; Suishan Qiu; Zhuanzhi Liang. Establishment of Microbial Limit Test for Hospital Preparation ‘Compound Alum Powder’. Eur. J. Clin. Biomed. Sci. 2021, 7(2), 33-36. doi: 10.11648/j.ejcbs.20210702.14
AMA Style
Fangming Tan, Minna Huang, Suishan Qiu, Zhuanzhi Liang. Establishment of Microbial Limit Test for Hospital Preparation ‘Compound Alum Powder’. Eur J Clin Biomed Sci. 2021;7(2):33-36. doi: 10.11648/j.ejcbs.20210702.14
@article{10.11648/j.ejcbs.20210702.14, author = {Fangming Tan and Minna Huang and Suishan Qiu and Zhuanzhi Liang}, title = {Establishment of Microbial Limit Test for Hospital Preparation ‘Compound Alum Powder’}, journal = {European Journal of Clinical and Biomedical Sciences}, volume = {7}, number = {2}, pages = {33-36}, doi = {10.11648/j.ejcbs.20210702.14}, url = {https://doi.org/10.11648/j.ejcbs.20210702.14}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ejcbs.20210702.14}, abstract = {Background: the assessment of microbiological quality of medicinal products is one of control stages in medicinal products saft, because the holder of a manufacturing authorization must drug so as to ensure that they are fit for their intended use, comply with the requirements of the Marketing Authorization and do not place patients at risk due to inadequate safety, quality or efficacy. Objective: To assess microbial limit test for hospital preparation ‘compound alum powder’. Methods: The results of strain culture and analysis were used to evaluate the drug quality of ‘compound alum powder’. The objective is ‘compound alum powder’ (approval number: Z20140229) was made by the First Affiliated Hospital of Jinan University. Their batch numbers include: 201019, 200818, 200701. Validation tests were carried out in accordance with the standards of the Chinese Pharmacopoeia (2020 edition). Three parallel independent validations were conducted to calculate the recovery rate of each test bacterium and investigate whether each test bacterium was detected in the control bacterial inspection. Result: The recovery ratio of the total number of aerobic bacteria, molds and yeast in the control group was in the range of 0.5 ~ 2, and the results of the control group were positive, and the results of each control group met the requirements. The results show that the membrane filtration method is suitable for the microbial limit test of ‘compound alum powder’. Conclusion: this microbial limit test method control and ensure the quality of drug production by solving the problem of interference of antimicrobial components in drugs. It can eliminate the bacteriostasis of boric acid, phenol and alum.}, year = {2021} }
TY - JOUR T1 - Establishment of Microbial Limit Test for Hospital Preparation ‘Compound Alum Powder’ AU - Fangming Tan AU - Minna Huang AU - Suishan Qiu AU - Zhuanzhi Liang Y1 - 2021/05/21 PY - 2021 N1 - https://doi.org/10.11648/j.ejcbs.20210702.14 DO - 10.11648/j.ejcbs.20210702.14 T2 - European Journal of Clinical and Biomedical Sciences JF - European Journal of Clinical and Biomedical Sciences JO - European Journal of Clinical and Biomedical Sciences SP - 33 EP - 36 PB - Science Publishing Group SN - 2575-5005 UR - https://doi.org/10.11648/j.ejcbs.20210702.14 AB - Background: the assessment of microbiological quality of medicinal products is one of control stages in medicinal products saft, because the holder of a manufacturing authorization must drug so as to ensure that they are fit for their intended use, comply with the requirements of the Marketing Authorization and do not place patients at risk due to inadequate safety, quality or efficacy. Objective: To assess microbial limit test for hospital preparation ‘compound alum powder’. Methods: The results of strain culture and analysis were used to evaluate the drug quality of ‘compound alum powder’. The objective is ‘compound alum powder’ (approval number: Z20140229) was made by the First Affiliated Hospital of Jinan University. Their batch numbers include: 201019, 200818, 200701. Validation tests were carried out in accordance with the standards of the Chinese Pharmacopoeia (2020 edition). Three parallel independent validations were conducted to calculate the recovery rate of each test bacterium and investigate whether each test bacterium was detected in the control bacterial inspection. Result: The recovery ratio of the total number of aerobic bacteria, molds and yeast in the control group was in the range of 0.5 ~ 2, and the results of the control group were positive, and the results of each control group met the requirements. The results show that the membrane filtration method is suitable for the microbial limit test of ‘compound alum powder’. Conclusion: this microbial limit test method control and ensure the quality of drug production by solving the problem of interference of antimicrobial components in drugs. It can eliminate the bacteriostasis of boric acid, phenol and alum. VL - 7 IS - 2 ER -